AstraZeneca to spend $50-billion to expand manufacturing, research capabilities in U.S.

  • Posted on July 21, 2025
  • By The Globe and Mail
  • 1 Views
AstraZeneca to spend $50-billion to expand manufacturing, research capabilities in U.S.

Investment will fund drug manufacturing facility in Virginia and expand research and development and cell therapy manufacturing in other states, company says
continue reading...

Author
The Globe and Mail

You May Also Like